AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Novorapid Penfill (3ml Each)

Prescription Icon
Prescription Required

Marketer

Novo Nordisk India Pvt Ltd

Salt Composition

Insulin Aspart (100IU)

Overview Novorapid Penfill (3ml Each)

Insulin Novorapid Penfill (3ml vials) manages blood glucose in individuals with type 1 and type 2 diabetes. This rapid-acting insulin lowers post-meal blood sugar, mitigating the risk of diabetes-related complications. Novorapid Penfill (3ml vials) is typically prescribed alongside a long-acting insulin or other diabetic medications. Your healthcare provider will instruct you on subcutaneous injection technique. Administer it at meal onset or within 20 minutes of eating. Regular blood glucose monitoring, record-keeping, and result sharing with your doctor are crucial for dose optimization. Avoid use with low blood sugar (hypoglycemia). Disclose any pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or breastfeeding individuals require physician consultation for potential dose adjustments. Discontinue only under medical supervision. This medication forms part of a comprehensive program encompassing diet, exercise, and weight management as directed by your doctor. Common adverse effects include hypoglycemia, headache, nasopharyngitis, and upper respiratory infections. Precise dosing, regular meals, and consistent blood glucose monitoring help prevent these. Excessive alcohol consumption can also trigger hypoglycemia. Additional side effects may include injection site reactions such as redness, swelling, or lipodystrophy. Weight gain is a possible consequence for some users.

Uses of Novorapid Penfill (3ml Each)

Managing Diabetic Conditions

Major Benefits of Novorapid Penfill (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Novorapid Penfill (3ml Each):

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Upper respiratory tract infection

How to use Novorapid Penfill (3ml Each):

Your healthcare provider will instruct you on the proper administration of this medication.

How Novorapid Penfill (3ml Each) works:

Rapid-acting insulin, Novorapid Penfill (3ml vials), takes effect within 10 to 20 minutes of administration. Its action mimics the body's natural insulin production, promoting glucose absorption by muscle and fat tissues while simultaneously inhibiting hepatic glucose release.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Novorapid Penfill (3ml vials) with alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Novorapid Penfill (3ml vials) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Insulin Aspart (3ml Penfill) is compatible with breastfeeding. Research in humans indicates minimal transfer of the medication into breast milk, posing no known risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Novorapid Penfill (3ml vials) cautiously, as dosage modifications may be necessary. Consult your physician for guidance. Routine blood glucose level checks are advised to optimize dosage.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Novorapid Penfill (3ml cartridges). Dosage modification of Novorapid Penfill (3ml cartridges) may be necessary. Physician consultation is recommended. Close and consistent blood glucose monitoring is advised.

What if you forget to take Novorapid Penfill (3ml Each) :

Delayed administration of Novorapid Penfill (3ml vials) may lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust subsequent dosing as needed.

Facts to Know About Novorapid Penfill (3ml Each)

LabelValue
Chemical Type Insulin analog
Developing Habits No.
Type of Therapy Diabetes Treatment
Action Class Fast-acting insulin analogs

FAQs on Novorapid Penfill (3ml Each)

Novorapid Penfill (3ml vials) is an insulin analog, an anti-diabetic medication for adults and children aged 2 and older. It helps manage blood sugar and improve glycemic control.
Novorapid Penfill (3ml vials) is a rapid-acting insulin analog produced via recombinant DNA technology using *Saccharomyces cerevisiae*. This sterile, clear, colorless solution contains insulin aspart and excipients including glycerin, phenol, metacresol, zinc, and sodium chloride.
Novorapid Penfill (3ml) dosage is individualized. Always use it as directed by your doctor, typically in combination with intermediate- or long-acting insulin. Inject subcutaneously 5-10 minutes before a meal, ensuring you eat within 10 minutes to prevent hypoglycemia. Alternatively, it may be injected immediately after a meal.
Yes, using Novorapid Penfill (3ml Each), whether alone or with other insulins, frequently leads to weight gain. This is because insulin reduces glucose excretion in urine and promotes fat and protein synthesis. To understand the specific cause and management options in your case, consult your physician.
Type 1 diabetes requires lifelong Novorapid Penfill (3ml Each) injections because the body doesn't produce enough insulin. Conversely, for type 2 diabetes, Novorapid Penfill (3ml Each) may be discontinued if blood sugar is well-managed through diet, exercise, and oral medications.
Novorapid Penfill can cause low blood sugar (hypoglycemia), characterized by symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always keep a fast-acting sugar source, such as candy, glucose biscuits, or juice, readily available.
Novorapid Penfill (3ml each) is a rapid-acting insulin used to manage blood sugar in people with diabetes. Its quick onset compared to regular insulin helps control blood sugar spikes after meals. Inject subcutaneously 5-10 minutes before meals; if a dose is missed, it can be injected afterward.
Using Novorapid Penfill (3ml Each) during pregnancy is safe when prescribed and monitored by your doctor. Expect adjustments to your dosage and increased blood glucose monitoring. Consult your doctor before or during pregnancy if you're using Novorapid Penfill (3ml Each).
Novorapid Penfill (3ml Ea...
850
MRP 937
9% off